ERYTECH Announces Management Change admERY January 4, 2016 Newsroom ERYTECH today announced that Yann Godfrin will be leaving the company to pursue new entrepreneurial projects. You Might Also Like ERYTECH Announces Publication of its Phase 2b Trial of Eryaspase in Metastatic Pancreatic Cancer in the European Journal of Cancer November 25, 2019 ERYTECH announces presentation and webcast at the Jefferies 2015 Healthcare Conference June 2, 2015 ERYTECH to Present at the 2021 BIO CEO & Investor Conference February 10, 2021
ERYTECH Announces Publication of its Phase 2b Trial of Eryaspase in Metastatic Pancreatic Cancer in the European Journal of Cancer November 25, 2019
